| Literature DB >> 29053957 |
Isabel C Lopez-Mejia1, Sylviane Lagarrigue2, Albert Giralt3, Laia Martinez-Carreres3, Nadège Zanou4, Pierre-Damien Denechaud1, Judit Castillo-Armengol3, Carine Chavey5, Meritxell Orpinell2, Brigitte Delacuisine1, Anita Nasrallah3, Caterina Collodet6, Lianjun Zhang7, Benoît Viollet8, D Grahame Hardie9, Lluis Fajas10.
Abstract
The roles of CDK4 in the cell cycle have been extensively studied, but less is known about the mechanisms underlying the metabolic regulation by CDK4. Here, we report that CDK4 promotes anaerobic glycolysis and represses fatty acid oxidation in mouse embryonic fibroblasts (MEFs) by targeting the AMP-activated protein kinase (AMPK). We also show that fatty acid oxidation (FAO) is specifically induced by AMPK complexes containing the α2 subunit. Moreover, we report that CDK4 represses FAO through direct phosphorylation and inhibition of AMPKα2. The expression of non-phosphorylatable AMPKα2 mutants, or the use of a CDK4 inhibitor, increased FAO rates in MEFs and myotubes. In addition, Cdk4-/- mice have increased oxidative metabolism and exercise capacity. Inhibition of CDK4 mimicked these alterations in normal mice, but not when skeletal muscle was AMPK deficient. This novel mechanism explains how CDK4 promotes anabolism by blocking catabolic processes (FAO) that are activated by AMPK. CrownEntities:
Keywords: AMPK; CDK4; FAO; metabolism; mitochondria
Mesh:
Substances:
Year: 2017 PMID: 29053957 DOI: 10.1016/j.molcel.2017.09.034
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970